Amylyx Pharmaceuticals (AMLX) Return on Assets (2022 - 2026)
Amylyx Pharmaceuticals (AMLX) posted quarterly Return on Assets of 0.01% for Q1 2026, little changed year-over-year from 0.01% in Q1 2025, and down 53.27% quarter-over-quarter from 0.0% in Q4 2025.
Amylyx Pharmaceuticals (AMLX) Return on Assets (2022 - 2026) Analysis & Trends
Amylyx Pharmaceuticals' Return on Assets history runs 5 years deep, the most recent figure standing at 0.01% for Q1 2026.
- In Q1 2026, Return on Assets changed 0.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (changed 0.0% YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
- Return on Assets for Q1 2026 stood at 0.01%, down from 0.0% in the prior quarter.
- The five-year high for Return on Assets was 0.0% in Q4 2023, with the low at 0.01% in Q4 2024.
- The 5-year median for Return on Assets is 0.01% (2025), against an average of 0.01%.
- The sharpest annual moves came in 2023 and 2024: Return on Assets rose 1 bps in 2023, then decreased 1 bps in 2024.
- Amylyx Pharmaceuticals' Return on Assets stood at 0.01% in 2022, then jumped by 114 bps to 0.0% in 2023, then plunged by 1219 bps to 0.01% in 2024, then jumped by 61 bps to 0.0% in 2025, then sank by 53 bps to 0.01% in 2026.
- Business Quant data shows AMLX's Return on Assets at 0.01% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.71 Bn | 42.75 Bn | - | 0.00% |
| 2 | Teva Pharmaceutical Industries | 43.11 Bn | 39.45 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.62 Bn | 29.94 Bn | 1.05 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 28.72 Bn | 22.92 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.33 Bn | 19.67 Bn | 683.80 Mn | 0.00% |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 0.00% |
| 8 | Elanco Animal Health | 12.10 Bn | 11.57 Bn | 798.00 Mn | 0.00% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 0.00% |
| 10 | Amylyx Pharmaceuticals | 4.28 Bn | 4.28 Bn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01% |
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |